•
CR
CRIS
Curis Inc
polygonBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
11.57M
Volume
165.87K
52W High
$3.65
52W Low
$0.77
Open
$0.90
Prev Close
$0.90
Day Range
0.90 - 0.95
About Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Latest News
Curis (CRIS) Q2 Loss Narrows 66%
The Motley Fool•Aug 5
VISTA Inhibitor Clinical Trials Drug Approval Insight - GlobeNewswire
GlobeNewswire Inc.•Jul 11
Top 3 Health Care Stocks That May Collapse In Q2
Benzinga•Apr 12
Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
Zacks Investment Research•Apr 5
CyberArk Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga•Feb 9
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga•Jan 24
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga•Nov 17
Curis shares rise as analysts see 'the next Pharmacyclics'
MarketWatch•Nov 17